As the world leader in digital medication adherence monitoring for successful clinical trials, AARDEX is proud to announce its collaboration with 4 Belgian/Swiss financial partners to assist company’s growth.

Clearly it is in no one’s interests for a clinical trial to fail. Whenever these high-stake activites are abandoned and drug development pathways are aborted, missed opportunities abound. Beyond the sponsor’s missed commercial opportunity, there are missed opportunities to advance